PT-0511

N/A

Report date: 2025/12/31 17:33:33

Base Information

Drug NamePT-0511
Drug Alias NamePT-0511PT0511
ClassificationOther
Mechanisms of ActionGTPase KRas degraders
TargetsGTPase KRas
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPAQ Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPAQ Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A